Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Stemtech (STEK) Cost of Revenue (2021 - 2025)

Stemtech's Cost of Revenue history spans 6 years, with the latest figure at $8061.0 for Q3 2025.

  • On a quarterly basis, Cost of Revenue fell 63.35% to $8061.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $421169.0, a 75.45% increase, with the full-year FY2024 number at $1.3 million, up 390.69% from a year prior.
  • Cost of Revenue hit $8061.0 in Q3 2025 for Stemtech, down from $126820.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for STEK hit a ceiling of $706994.0 in Q4 2021 and a floor of -$256169.0 in Q4 2022.
  • Historically, Cost of Revenue has averaged $155469.7 across 5 years, with a median of $126820.0 in 2025.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 925.64% in 2021 and later plummeted 136.23% in 2022.
  • Tracing STEK's Cost of Revenue over 5 years: stood at $706994.0 in 2021, then crashed by 136.23% to -$256169.0 in 2022, then surged by 54.4% to -$116801.0 in 2023, then soared by 329.96% to $268593.0 in 2024, then plummeted by 97.0% to $8061.0 in 2025.
  • Business Quant data shows Cost of Revenue for STEK at $8061.0 in Q3 2025, $126820.0 in Q2 2025, and $17695.0 in Q1 2025.